Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation
Status:
Terminated
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the best strategy for long-term stroke prevention
in patients who have sinus rhythm after a successful catheter ablation for atrial
fibrillation (AF) and who are at risk of thromboembolic events (CHA2DS2-VASc score ≥2). The
investigators are going to compare antiplatelet therapy to oral anticoagulation (OAC) with
different doses of edoxaban (30mg and 60mg).